Harnessing Predictive Biomarkers and Unveiling Biological Mechanisms to Revolutionize Schizophrenia Treatment
Science / Life Sciences
This project is focused on examining proteins and lipids in blood plasma obtained from schizophrenia patients. The goal is to uncover biomarkers, which have been elusive until now, that can predict the effectiveness of specific medications. The biochemical pathways implicated in the onset and progression of schizophrenia will also be studied in human brain tissue and pre-clinical models. A deeper understanding of the disorder’s molecular underpinnings could pave the way for developing a targeted therapeutic strategy.
Amount invested
Grant Serrapilheira: R$ 100.000,00
